B7-33
A synthetic peptide derived from relaxin-2, studied in laboratory and animal research on fibrosis.
- Type
- Peptide
- Research area
- Recovery research
- Research stage
- Laboratory and animal research
- FDA status
- Not an FDA-approved medicine
About B7-33
A synthetic peptide derived from relaxin-2, studied in laboratory and animal research on fibrosis.
Where the research stands
Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.
Read the studies
Educational information only; not medical advice. Talk to a licensed doctor before using any compound.
Common questions
Is B7-33 an FDA-approved medicine?
No. B7-33 is not an FDA-approved medicine. Research stage: Laboratory and animal research.
Does EKO Labs sell B7-33?
No. EKO Labs does not sell B7-33 or any research compound. This library is for education only. EKO Labs offers FDA-approved prescription treatments only after a licensed doctor decides they are right for you.
Can people use B7-33?
This page does not cover personal use. Products labeled "research use only" are not made or approved for people. Ask a licensed doctor before using any compound.
Related compounds
C62H98N16O22BPC-157BPC-157
A stomach-protein fragment studied mainly in animal models of tissue healing.
C38H68N10O14TB-500TB-500
A synthetic fragment of thymosin beta-4 studied in cell and animal research.
C16H30N4O4KPVKPV
A three-amino-acid peptide studied in laboratory inflammation research.